These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8873002)

  • 1. Antimitochondrial antibodies in patients with chronic hepatitis C.
    Grimbert S; Johanet C; Bendjaballah F; Homberg JC; Poupon R; Beaugrand M
    Liver; 1996 Jun; 16(3):161-5. PubMed ID: 8873002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis.
    Mutimer DJ; Fussey SP; Yeaman SJ; Kelly PJ; James OF; Bassendine MF
    Hepatology; 1989 Oct; 10(4):403-7. PubMed ID: 2673968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies.
    Moteki S; Leung PS; Coppel RL; Dickson ER; Kaplan MM; Munoz S; Gershwin ME
    Hepatology; 1996 Jul; 24(1):97-103. PubMed ID: 8707289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactivity of antimitochondrial autoantibodies in Japanese patients with primary biliary cirrhosis.
    Omagari K; Rowley MJ; Jois JA; Feeney SJ; Komatsu K; Maeda T; Onishi S; Yamazaki K; Suzuki K; Galperin C; Mackay IR
    J Gastroenterol; 1996 Feb; 31(1):61-8. PubMed ID: 8808430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary biliary cirrhosis. Quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression.
    Heseltine L; Turner IB; Fussey SP; Kelly PJ; James OF; Yeaman SJ; Bassendine MF
    Gastroenterology; 1990 Dec; 99(6):1786-92. PubMed ID: 2227292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoblotting as a confirmatory test for antimitochondrial antibodies in primary biliary cirrhosis.
    Provenzano G; Diquattro O; Craxì A; Almasio P; Pinzello G; Marino L; Fiorentino G; Rinaldi F; Pagliaro L
    Gut; 1993 Apr; 34(4):544-8. PubMed ID: 8491404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of anti-M2 antibodies after liver transplantation for primary biliary cirrhosis.
    Dubel L; Farges O; Bismuth H; Sebagh M; Homberg JC; Johanet C
    J Hepatol; 1995 Dec; 23(6):674-80. PubMed ID: 8750166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimitochondrial antibody profiles in patients with primary biliary cirrhosis before orthotopic liver transplantation and titres of antimitochondrial antibody-subtypes after transplantation.
    Klein R; Huizenga JR; Gips CH; Berg PA
    J Hepatol; 1994 Feb; 20(2):181-9. PubMed ID: 8006398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to treatment with interferon-alfa in patients with chronic hepatitis C and high titers of -M2, -M4 and -M8 antimitochondrial antibodies.
    Garrido Palma G; Sánchez Cuenca JM; Olaso V; Pina R; Urquijo JJ; López Viedma B; Bustamante M; Berenguer M; Berenguer J
    Rev Esp Enferm Dig; 1999 Mar; 91(3):168-81. PubMed ID: 10231308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sjögren's syndrome and primary biliary cirrhosis: presence of autoantibodies to purified mitochondrial 2-OXO acid dehydrogenases.
    Fujikura S; Davis PA; Prindiville T; Leung P; Fox RI; Gershwin ME
    J Rheumatol; 1990 Nov; 17(11):1453-7. PubMed ID: 1703233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary biliary cirrhosis: lessons learned from an organ-specific disease.
    Nishio A; Keeffe EB; Gershwin ME
    Clin Exp Med; 2001 Dec; 1(4):165-78. PubMed ID: 11918275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimitochondrial antibody-negative primary biliary cirrhosis.
    Lacerda MA; Ludwig J; Dickson ER; Jorgensen RA; Lindor KD
    Am J Gastroenterol; 1995 Feb; 90(2):247-9. PubMed ID: 7847294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of antimitochondrial antibodies with the M2-M4 pattern by immunofluorescence as assessed by Western immunoblotting and enzyme linked immunosorbent assay.
    Fusconi M; Ghadiminejad I; Bianchi FB; Baum H; Bottazzo GF; Pisi E
    Gut; 1988 Apr; 29(4):440-7. PubMed ID: 2453397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimitochondrial antibodies in kindreds of patients with primary biliary cirrhosis: antimitochondrial antibodies are unique to clinical disease and are absent in asymptomatic family members.
    Caldwell SH; Leung PS; Spivey JR; Prindiville T; de Medina M; Saicheur T; Rowley M; Reddy KR; Coppel R; Jeffers LJ
    Hepatology; 1992 Oct; 16(4):899-905. PubMed ID: 1398496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.
    Czaja AJ; Carpenter HA; Manns MP
    Gastroenterology; 1993 Nov; 105(5):1522-8. PubMed ID: 8224657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis.
    Van de Water J; Cooper A; Surh CD; Coppel R; Danner D; Ansari A; Dickson R; Gershwin ME
    N Engl J Med; 1989 May; 320(21):1377-80. PubMed ID: 2716784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversity of autoantibodies in patients with antimitochondrial antibody and their diagnostic value.
    McMillan SA; Alderdice JM; McKee CM; Dawson AT; Callender ME; Fulton TT; Haire M
    J Clin Pathol; 1987 Feb; 40(2):232-6. PubMed ID: 3546398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.
    Luettig B; Boeker KH; Schoessler W; Will H; Loges S; Schmidt E; Worman HJ; Gershwin ME; Manns MP
    J Hepatol; 1998 May; 28(5):824-8. PubMed ID: 9625318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies.
    Calleja JL; Albillos A; Cacho G; Iborra J; Abreu L; Escartín P
    J Hepatol; 1996 Mar; 24(3):308-12. PubMed ID: 8778197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.